Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 188 | 805 | 549 | 345 | 689 |
| Receivables | 37 | 104 | 101 | 36 | 57 |
| TOTAL | $258 | $921 | $694 | $405 | $756 |
| Non-Current Assets | |||||
| PPE Net | 34 | 45 | 71 | 101 | 133 |
| Intangibles | 963 | 901 | 807 | 722 | 629 |
| TOTAL | $996 | $945 | $878 | $823 | $761 |
| Total Assets | $1,254 | $1,866 | $1,572 | $1,229 | $1,518 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 88 | 93 |
| TOTAL | $91 | $69 | $80 | $88 | $93 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $N/A | $N/A |
| Total Liabilities | $91 | $69 | $80 | $88 | $93 |
| Shareholders' Equity | |||||
| Retained earnings | -7,265 | -6,292 | -5,415 | -4,338 | -3,248 |
| Other shareholders' equity | 288 | 312 | 736 | 70 | 0 |
| TOTAL | $1,164 | $1,797 | $1,493 | $1,141 | $1,425 |
| Total Liabilities And Equity | $1,254 | $1,866 | $1,572 | $1,229 | $1,518 |